Lipid nanoparticles in anti-breast cancer drug delivery systems and drug-membrane interactions
Current anticancer drugs are plagued with lack of sustained effect and poor delivery. Many current studies focus on the use of drug carriers, particularly lipid nanoparticles as new drug delivery systems. In this study, a nanostructured lipid carrier (NLC) was formulated to serve as a carrier...
Saved in:
Main Author: | How, Chee Wun |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2014
|
Online Access: | http://psasir.upm.edu.my/id/eprint/70806/1/FPV%202014%2012%20-%20IR.pdf http://psasir.upm.edu.my/id/eprint/70806/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loade nanostructured lipid carriers
by: Beh, Chaw Yee, et al.
Published: (2017) -
Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity
by: How, Chee Wun, et al.
Published: (2013) -
Drug delivery systems based on iron oxide magnetite-layered double hydroxide nanoparticles for liver anti-cancer drugs
by: Ebadi, Mona
Published: (2021) -
Development of multifunctional drug delivery systems based on virus-like nanoparticles for cancer targeting drug delivery
by: Biabanikhankahdani, Roya
Published: (2017) -
Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system
by: Beh, Chaw Yee, et al.
Published: (2019)